Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Severe Malaria and Leptospirosis Are Associated with a Deficiency of the Von Willebrand Factor Cleaving Protease, ADAMTS13

Bibliographic Details
Main Authors:	Lowenberg, E, Cohen, S, van den Born, B, Meijers, J, Levi, M, Dondorp, A
Format:	Conference item
Published:	2008

Similar Items

Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
by: Löwenberg, E, et al.
Published: (2010)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
by: Birnie, E, et al.
Published: (2017)

The von Willebrand factor – ADAMTS‐13 axis in malaria
by: Andrew S. O’Donnell, et al.
Published: (2022-01-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
by: Stefano Lancellotti, et al.
Published: (2013-09-01)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
by: Emma Birnie, et al.
Published: (2017-03-01)

Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease.
by: Zuben E Sauna, et al.
Published: (2009-08-01)

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory
by: J-D Studt, et al.
Published: (2003-06-01)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
by: Emma Birnie, et al.
Published: (2020-09-01)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
by: Gurbey Ocak, et al.
Published: (2021-06-01)

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
by: Chanukya K. Colonne, et al.
Published: (2022-03-01)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
by: Benjamin Reardon, et al.
Published: (2021-09-01)

Púrpura trombocitopênica trombótica: o papel do fator von Willebrand e da ADAMTS13 Thrombotic thrombocytopenic purpura: the role of von Willebrand factor and ADAMTS13
by: Leandro C. Tonaco, et al.
Published: (2010-01-01)

Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease
by: Nataliya Dolgushina, et al.
Published: (2022-07-01)

The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
by: Stefano Lancellotti, et al.
Published: (2022-04-01)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
by: Waldemar E. Wysokinski, MD, PhD, et al.
Published: (2021-03-01)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
by: Kanwal Singh, et al.
Published: (2021-01-01)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
by: Dalia A. Bashir MD, et al.
Published: (2021-02-01)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
by: R.P.S. Soares, et al.
Published: (2013-04-01)

Comparison of levels of von Willebrand factor and ADAMTS13 in Patients of Myocardial Infarction and Healthy Controls
by: Shamila Tahir, et al.
Published: (2019-05-01)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
by: Junxian Yang, et al.
Published: (2020-12-01)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
by: R.P.S. Soares, et al.
Published: (2013-05-01)

Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty
by: Jun Kit He, et al.
Published: (2022-10-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

Matrilin-2 Is Proteolytically Cleaved by ADAMTS-4 and ADAMTS-5
by: Zhengke Wang, et al.
Published: (2014-06-01)

The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
by: Giovanni Tiscia, et al.
Published: (2021-09-01)

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study
by: Hanna L. Obermeier, et al.
Published: (2019-07-01)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
by: Julien Demagny, et al.
Published: (2021-01-01)

Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery
by: Katja Susanne Häußler MD, et al.
Published: (2020-10-01)

Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
by: Caroline Pereira Domingueti, et al.
Published: (2015-01-01)

The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure
by: Hiroaki Takaya, et al.
Published: (2023-01-01)

A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.
by: Christopher J Lynch, et al.
Published: (2017-01-01)

Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection
by: Quan Zhang, et al.
Published: (2023-11-01)

A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
by: Jingyu Zhang, et al.
Published: (2011-01-01)

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
Published: (2011-01-01)

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13.
by: Jingyu Zhang, et al.
Published: (2011-01-01)

Association of ADAMTS13 polymorphism with cerebral malaria
by: Kraisin Sirima, et al.
Published: (2011-12-01)

Regulation of ADAMTS Proteases
by: Keron W. J. Rose, et al.
Published: (2021-06-01)

ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice
by: Naamah L. Zitomersky, et al.
Published: (2017-06-01)

Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population
by: Zongkui Wang, et al.
Published: (2017-03-01)